Fig 2 - by Mina Dawod (18933969)

Subjects:

Fig 3 - by Mina Dawod (18933969)

Subjects:

CT utilization rates for each combination of sex, age (in years), SES SVI vulnerability quartile, and BMI. by Mina Dawod (18933969)

Subjects:

MR utilization rates for each combination of sex, age (in years), SES SVI vulnerability quartile, and BMI. by Mina Dawod (18933969)

Subjects:

Number of patients (in millions) in each BMI cohort included in the study population (Total), stratified by age, sex, and socioeconomic status (SES) vulnerability quartile. by Mina Dawod (18933969)

Subjects:

Multiple logistic regression model exploring factors associated with >50% seizures reduction at month 4. by Michel Mandro (2637532)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Linear regression analysis of relation between TBI/ABI (0.1 unit) and CIMT (1mm). by Gisoo Darban Hosseini Amirkhiz (10974784)

Subjects:

Amygdala (a), temporal lobe (b), and basal ganglia (d) showed decreased entropy values in TC patients vs controls (p<0.01). by Jennifer A. Ogren (10164100)

Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)

Viscosity and zeta potential for 0.1% FLU ophthalmic suspensions used in this study. by Tokio Obata (10783047)

Changes in the melting points of each formulation of 0.1% FLU ophthalmic suspensions. by Tokio Obata (10783047)

Changes in the viscosity of 0.1% FLU ophthalmic suspensions of each formulation with temperature. by Tokio Obata (10783047)

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. by Michael Gulledge (20577135)

Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation. by Juanita K. Hodax (6848540)

Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

Dose- and time-dependent effect of IL-13, IL-4, and TGF-β1 on benzamil-sensitive <i>I</i>_sc and TEER in HBECs. by Anusree Sasidharan (19226521)

Conditioning with glucose and sodium ions decreases chemotaxis to sodium ions and glucose, respectively. by Masahiro Tomioka (430683)